Stock INDV INDIVIOR PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Indivior PLC

Equities

INDV

GB00BN4HT335

Real-time Estimate Cboe Europe
Other stock markets
 09:40:36 2024-04-26 am EDT 		5-day change 1st Jan Change
1,392 GBX -0.57% Intraday chart for Indivior PLC -8.92% +16.37%
Apr. 25 Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 25 London-listed Indivior Confirms Plan for Primary Listing in US MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024
London-listed Indivior Confirms Plan for Primary Listing in US
MT
Indivior Seeks Shareholder Nod for Listing in the United States
CI
UK-listed drugmaker Indivior seeks shareholder nod for US listing
RE
Indivior shares down despite profit boost on planned shift to New York
AN
Indivior Reports Higher Q1 Net Income, Net Revenue
MT
Indivior plc Reconfirms Earnings Guidance for 2024
CI
Indivior PLC Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Craig-Hallum Starts Indivior With Buy Rating, $37 Price Target
MT
Indivior : Draft rules of the Indivior 2024 UK Savings Related Share Option Plan to be considered at the 2024 AGM
PU
Indivior : Draft rules of the Indivior 2024 Long-Term Incentive Plan to be considered at the 2024 AGM
PU
C4X Discovery seeks AIM delisting but half-year revenue skyrockets
AN
Indivior PLC Appoints David E. Wheadon, M.D. as Independent Non-Executive Director, Effective from June 1, 2024
CI
Indivior CCO Richard Simkin sells GBP1 million in shares
AN
Indivior : Annual Report and Accounts for year ended 31 December, 2023.
PU
UBS cuts abrdn price target but ups Darktrace's
AN
Indivior Says Opvee Shows Drug Reverses Opioid-Induced Respiratory Depression Faster Than Naloxone
MT
Indivior PLC Announces Publication Demonstrating that OPVEE® Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
CI
Indivior chief commercial officer sells GBP500,000 in shares
AN
Oxford Nanopore Technologies top team buys shares
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INDV Stock
  4. News Indivior PLC